Heartflow, Inc. Common Stock (HTFL) Stock Price

HTFLStock

$48.29+44.28%52W

Market Cap$4.20B

P/E—

PEG Ratio—

Div yield—

Beta1.62

HTFL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)56.33%

Price vs S&P 500 (4W)-2.73%

VGM Score60.13

Book Value / Share (Quarterly)$3.23

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.68

Price vs S&P 500 (YTD)53.73%

Gross Margin (TTM)80.08%

Net Profit Margin (TTM)-55.82%

EPS (TTM)$-1.82

10-Day Avg Trading Volume1.67M

EPS Excl Extra (TTM)$-1.82

EPS (Annual)$-3.17

ROI (Annual)-38.85%

Gross Margin (Annual)76.80%

Cash / Share (Quarterly)$1.87

Revenue Growth QoQ (YoY)47.57%

ROA (Last FY)-32.49%

EBITD / Share (TTM)$-1.06

Operating Margin (TTM)-40.84%

Cash Flow / Share (Annual)$-0.69

P/B Ratio15.01x

P/B Ratio (Quarterly)9.05x

Net Income / Employee (Annual)$-138,500

EV / Revenue (TTM)19.64x

Net Interest Coverage (TTM)-1.53x

ROA (TTM)-33.53%

EPS Incl Extra (Annual)$-3.17

Current Ratio (Annual)5.20x

Quick Ratio (Quarterly)4.66x

3-Month Avg Trading Volume1.88M

52-Week Price Return44.28%

Revenue / Employee (TTM)$251,600

P/S Ratio (Annual)23.85x

Asset Turnover (Annual)0.49x

52-Week High$54.32

EPS Excl Extra (Annual)$-3.17

26-Week Price Return66.23%

Quick Ratio (Annual)4.87x

13-Week Price Return94.09%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.08x

Enterprise Value$4.16B

Asset Turnover (TTM)0.60x

Revenue / Employee (Annual)$208,800

Pretax Margin (Annual)-66.39%

Cash / Share (Annual)$2.07

3-Month Return Std Dev85.40%

Net Income / Employee (TTM)$-140,400

ROE (Last FY)-38.85%

Net Interest Coverage (Annual)-1.12x

EPS Basic Excl Extra (Annual)$-3.17

Receivables Turnover (TTM)5.85x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.82

ROI (TTM)-42.25%

P/S Ratio (TTM)19.80x

Revenue / Share (Annual)$4.78

Price vs S&P 500 (52W)28.75%

Year-to-Date Return65.66%

5-Day Price Return-4.49%

EPS Normalized (Annual)$-3.17

Net Profit Margin (Annual)-66.35%

Month-to-Date Return-2.93%

EBITD / Share (Annual)$-1.76

Operating Margin (Annual)-40.01%

LT Debt / Equity (Annual)0.00x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.82

P/B Ratio (Annual)8.26x

Pretax Margin (TTM)-55.86%

Book Value / Share (Annual)$3.53

Price vs S&P 500 (13W)91.41%

Beta1.62x

Revenue / Share (TTM)$2.45

ROE (TTM)-42.25%

52-Week Low$20.13

vGradeF

gGradeA

mGradeA

vgmGradeB

HTFL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.13	-$0.07	+47.85%(+$0.06)
Q1 2026	May 14, 2026	-$0.17	-$0.16	+8.49%(+$0.01)
Q4 2025	Mar 18, 2026	-$0.16	-$0.12	+23.18%(+$0.04)
Q3 2025	Nov 12, 2025	-$0.24	-$0.27	-12.50%(-$0.03)
Q2 2025	Sep 19, 2025	-$0.21	-$1.10	-417.44%(-$0.89)

HTFL Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.15

4.20

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Heartflow, Inc. Common Stock

HeartFlow Inc develops AI-powered software solutions for non-invasive diagnosis and management of coronary artery disease. The company operates through a single business segment focused on digital cardiovascular diagnostics. With strong revenue concentration in the United States, HeartFlow also serves markets in the United Kingdom, Japan, and Europe.

HTFL Next Earnings Report

Report dateNov 11, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.10

Revenue estimate$65.20M

Also reporting on Nov 11, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

HTFL Insider Transactions

SellSep 18, 2026
ROGERS CAMPBELL M.D.
Officer
Shares: 19,682Value: $987,052
SellSep 15, 2026
VERGHESE VIKRAM
Chief Financial Officer
Shares: 34,975Value: $1.75M
SellSep 11, 2026
FARQUHAR JOHN C. M.
Chief Executive Officer
Shares: 38,900Value: $1.82M
SellSep 8, 2026
VERGHESE VIKRAM
Chief Financial Officer
Shares: 6,640Value: $332,212
SellSep 3, 2026
VERGHESE VIKRAM
Chief Financial Officer
Shares: 33,416Value: $1.67M

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

BLCOBausch + Lomb CorporationOphthalmic Goods
VNTVontier CorporationFluid Meters
ITGRInteger Holdings CorporationElectromedical Equipment
LIVNLivaNova PLC Ordinary SharesElectromedical Equipment
MIRMirion Technologies, Inc.Measuring & Controlling Devices
NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share
BMIBadger Meter, Inc.Fluid Meters
ITRIItron IncInstruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Strong Buy

Consensus rating

52-Week Range

Low$20.13

High$54.32